BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7564434)

  • 1. Allograft heart valve sterilization: a six-year in-depth analysis of a twenty-five-year experience with low-dose antibiotics.
    Gall K; Smith S; Willmette C; Wong M; O'Brien M
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):680-7. PubMed ID: 7564434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Banking of cryopreserved heart valves in Europe: assessment of a 10-year operation in the European Homograft Bank (EHB).
    Goffin YA; Van Hoeck B; Jashari R; Soots G; Kalmar P
    J Heart Valve Dis; 2000 Mar; 9(2):207-14. PubMed ID: 10772038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control in homograft valve processing: when to screen for microbiological contamination?
    Soo A; Healy DG; El-Bashier H; Shaw S; Wood AE
    Cell Tissue Bank; 2011 Aug; 12(3):185-90. PubMed ID: 20490931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allograft heart valve viability and valve-processing variables.
    Gall KL; Smith SE; Willmette CA; O'Brien MF
    Ann Thorac Surg; 1998 Apr; 65(4):1032-8. PubMed ID: 9564923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart valve allograft decontamination with antibiotics: impact of the temperature of incubation on efficacy.
    Germain M; Thibault L; Jacques A; Tremblay J; Bourgeois R
    Cell Tissue Bank; 2010 May; 11(2):197-204. PubMed ID: 20390362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological examination of donated human cardiac tissue in heart valve banking.
    van Kats JP; van Tricht C; van Dijk A; van der Schans M; van den Bogaerdt A; Petit PL; Bogers AJ
    Eur J Cardiothorac Surg; 2010 Jan; 37(1):163-9. PubMed ID: 19709896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homograft valves.
    Barratt-Boyes B; Roche A; Agnew TM; Cole D; Kerr A; Monro JL; Lowe JB; Brandt PW
    Med J Aust; 1972 Aug; 2(1):Suppl:38-44. PubMed ID: 4637362
    [No Abstract]   [Full Text] [Related]  

  • 8. Are heart valves from donors over 65 years of age morphologically suitable for transplantation?
    Grosse K; Meyer R; Schmitzer E; Hetzer R; Wesslau C
    Cell Tissue Bank; 2008 Mar; 9(1):31-6. PubMed ID: 17846920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues surrounding the preservation of viable allograft heart valves.
    McNally RT; Brockbank KG
    J Med Eng Technol; 1992; 16(1):34-8. PubMed ID: 1640446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of decontamination process of heart valve and artery tissues in European Homograft Bank (EHB): a retrospective study of 1,055 cases.
    Fan YD; Van Hoeck B; Holovska V; Jashari R
    Cell Tissue Bank; 2012 Jun; 13(2):297-304. PubMed ID: 21512894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of high virulence microorganisms isolated in heart valve banking.
    Villalba R; Solis F; Fornés G; Jimenez A; Eisman M; González AI; Linares MJ; Casal M; Gómez Villagrán JL
    Cell Tissue Bank; 2012 Aug; 13(3):441-5. PubMed ID: 22618487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreserved semilunar heart valve allografts: leaflet surface damage in scanning electron microscopy.
    Burkert J; Krs O; Vojácek J; Mokrácek A; Slízová D; Hlubocký J; Kobylka P; Spatenka J
    Zentralbl Chir; 2008 Aug; 133(4):367-73. PubMed ID: 18702023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue valves.
    Wallace RB
    Am J Cardiol; 1975 Jun; 35(6):866-71. PubMed ID: 805517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decontamination of heart valve and arterial allografts in the European Homograft Bank (EHB): comparison of two different antibiotic cocktails in low temperature conditions.
    Jashari R; Tabaku M; Van Hoeck B; Cochéz C; Callant M; Vanderkelen A
    Cell Tissue Bank; 2007; 8(4):247-55. PubMed ID: 17440832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of aortic valve replacement with pulmonary and aortic homografts.
    Naegele H; Bohlmann M; Döring V; Kalmar P; Rödiger W
    J Heart Valve Dis; 2000 Mar; 9(2):215-20; discussion 220-1. PubMed ID: 10772039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of antibiotics and storage on the viability and ultrastructure of fibroblasts in canine heart valves prepared for grafting.
    Girinath MR; Gavin JB; Strickett MG; Barratt-Boyes BG
    Aust N Z J Surg; 1974 May; 44(2):170-2. PubMed ID: 4533466
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aortic valve replacement with fresh or cryopreserved aortic allograft--initial experience in Japan].
    Kitamura S; Niwaya K; Kawachi K; Morita R; Taniguchi S; Kawata T; Kobayashi S; Fukutomi M; Kameda Y; Hasegawa J
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):2035-9. PubMed ID: 1487635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allograft (homograft) valve surgery: current status in Japan].
    Kitamura S; Niwaya K; Kawachi K; Morita R; Kawata T; Kobayashi S; Fukutomi M; Hasegawa J; Yoshida Y; Sakaguchi H
    Rinsho Kyobu Geka; 1994 Aug; 14(4):273-9. PubMed ID: 9423100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A re-evaluation of antibiotic sterilisation of heart valve allografts.
    Wain WH; Pearce HM; Riddell RW; Ross DN
    Thorax; 1977 Dec; 32(6):740-2. PubMed ID: 601738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of decontamination protocol by antimicrobial treatment in Iranian Tissue Bank (ITB).
    Dashti-Khavidaki S; Dabardani F; Mahdavi-Mazdeh M; Ravanasa E; Hosseini SK
    Cell Tissue Bank; 2015 Sep; 16(3):381-8. PubMed ID: 25492102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.